| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/16/2009 | US20090181060 Skin-care compositions |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181057 Methods and Compositions for the Inhibition of Thrombus Formation |
| 07/16/2009 | US20090180971 Method for the prevention and/or activation of defense mechanisms in the human body against conditions, disorders or diseases relating to the presence of free radicals, such as: environmental pollution, aging or smoking |
| 07/16/2009 | US20090180970 Foamable composition combining a polar solvent and a hydrophobic carrier |
| 07/16/2009 | US20090180969 Pharmaceutical formulation comprising an anticholinergic drug |
| 07/16/2009 | US20090180968 Metal Coordination Complexes Of Volatile Drugs |
| 07/16/2009 | US20090180966 Cancer cell diagnosis by targeting delivery of nanodevices |
| 07/16/2009 | US20090180950 Polychromatic, diversely-sized particles for angiography |
| 07/16/2009 | US20090178673 Actuation Indicator for a Dispensing Device |
| 07/16/2009 | DE202009004127U1 Selbstaufblasender Schlauch als Magenfüller A self-Tube as a stomach filler |
| 07/16/2009 | DE10214226B4 Wirkstoffträger, Verfahren zu dessen Herstellung und Verwendung Drug carriers, methods for its preparation and use |
| 07/16/2009 | DE102008003999A1 Producing pharmaceutical preparations by buildup by means of application of thin layers, useful as medicaments or dietary supplements for humans and animals |
| 07/16/2009 | CA2749273A1 Pharmaceutical compositions |
| 07/16/2009 | CA2738458A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 07/16/2009 | CA2711862A1 Composition for improving nutritional status of the elderly, reducing frequency of fever of the elderley and/or increasing immunocompetence of the elderly |
| 07/16/2009 | CA2711814A1 Capsule formulation |
| 07/16/2009 | CA2711734A1 Method and compositions for administering resveratrol and pterostilbene |
| 07/16/2009 | CA2711687A1 Analgesic apatitic calcium-phosphate cement |
| 07/16/2009 | CA2711663A1 Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol |
| 07/16/2009 | CA2711554A1 Methods and compositions for oral administration of protein and peptide therapeutic agents |
| 07/16/2009 | CA2711475A1 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 07/16/2009 | CA2711474A1 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release |
| 07/16/2009 | CA2711473A1 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
| 07/16/2009 | CA2711292A1 Inhalation drug products, systems and uses |
| 07/16/2009 | CA2711236A1 Screening method for selected amino lipid-containing compositions |
| 07/16/2009 | CA2711114A1 Topical compositions for the controlled delivery of proteins and peptides |
| 07/16/2009 | CA2710988A1 Magnetic polymer pellets and their application methods |
| 07/16/2009 | CA2710986A1 Magnetic polymer pellets and a method of generating the blocking gel plug |
| 07/16/2009 | CA2710827A1 Silver nanoparticles with specific surface area and a method for producing them |
| 07/16/2009 | CA2710525A1 Nanodispersion |
| 07/16/2009 | CA2709992A1 Pharmaceutical composition |
| 07/16/2009 | CA2709521A1 Novel coated extended release pharmaceutical compositions of levetiracetam |
| 07/16/2009 | CA2708514A1 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/16/2009 | CA2706931A1 Oral pharmaceutical dosage forms |
| 07/16/2009 | CA2705285A1 Pharmaceutical formulations |
| 07/15/2009 | EP2078532A1 Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device |
| 07/15/2009 | EP2078528A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 07/15/2009 | EP2078527A1 Aqueous liquid preparation comprising gatifloxacin |
| 07/15/2009 | EP2078526A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 07/15/2009 | EP2078524A1 Adhesive skin patch |
| 07/15/2009 | EP2078522A1 Composition for treating allergy |
| 07/15/2009 | EP2078460A1 Process for preparing concentrate thickener compositions |
| 07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 07/15/2009 | EP2078042A1 Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| 07/15/2009 | EP2077850A2 Elvucitabine pharmaceutical compositions |
| 07/15/2009 | EP2077840A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 07/15/2009 | EP2077834A2 Formulations of phospholipase enzyme inhibitors |
| 07/15/2009 | EP2077825A2 Liquid formulations of phospholipase enzyme inhibitors |
| 07/15/2009 | EP2077824A2 Film embedded packaging and method of making same |
| 07/15/2009 | EP2077823A2 Method for precipitation of small medicament particles into use containers |
| 07/15/2009 | EP2077822A1 Oxcarbazepine-containing oral formulation and a process to obtain the same |
| 07/15/2009 | EP2077821A1 Compositions and methods for modulating immune responses |
| 07/15/2009 | EP2077820A1 Encapsulated soy extracts and process for preparing same |
| 07/15/2009 | EP2077819A2 Methods, kits, and compositions for generating new hair follicles and growing hair |
| 07/15/2009 | EP2077729A1 Probiotic oral dosage forms |
| 07/15/2009 | EP2077727A1 Chewing gum comprising hvdroxyapatite |
| 07/15/2009 | EP2077726A2 A work holder for use in and a method for making a lollipop |
| 07/15/2009 | EP1996199A4 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
| 07/15/2009 | EP1858483A4 Delivery system for multiple drugs |
| 07/15/2009 | EP1761243B1 Tobacco alkaloid releasing chewing gum |
| 07/15/2009 | EP1752141B1 Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer |
| 07/15/2009 | EP1750664B1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
| 07/15/2009 | EP1715893B1 Direct compression formulation and process |
| 07/15/2009 | EP1651190A4 Formulations containing an immune response modifier |
| 07/15/2009 | EP1631261B1 Production of small particles |
| 07/15/2009 | EP1622657A4 Dialysis valve and method |
| 07/15/2009 | EP1478428B1 Device and method for delivering or withdrawing a substance through the skin |
| 07/15/2009 | EP1446099B1 Injectable depot composition |
| 07/15/2009 | EP1395278B1 Ocular tear growth factor-like protein |
| 07/15/2009 | EP1389118B1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle |
| 07/15/2009 | EP1370268B1 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 07/15/2009 | EP1292381B1 Process and device for producing liquid dosage formulations |
| 07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
| 07/15/2009 | EP1063971B1 Controlled release oral tablet having a unitary core |
| 07/15/2009 | CN101484150A Controlled release composition and preparation thereof |
| 07/15/2009 | CN101484149A Pharmaceutical form with multilayer separating layer |
| 07/15/2009 | CN101484148A Coated tablets, their methods of preparation, and related uses |
| 07/15/2009 | CN101484147A Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 07/15/2009 | CN101484146A Xylitol troches and methods of use |
| 07/15/2009 | CN101484145A Compositions and method for the reduction of post-operative pain |
| 07/15/2009 | CN101484144A Compositions with controlled pharmacokinetics |
| 07/15/2009 | CN101484143A Pharmaceutical composition containing a tetrahydrofolic acid |
| 07/15/2009 | CN101484142A Stabilized compositions containing alkaline labile drugs |
| 07/15/2009 | CN101484141A A stable olanzapine formulation with antioxidants |
| 07/15/2009 | CN101484140A Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 07/15/2009 | CN101484139A Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 07/15/2009 | CN101484138A Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
| 07/15/2009 | CN101484137A Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same |
| 07/15/2009 | CN101484136A Pre-mixed, ready-to-use pharmaceutical compositions |
| 07/15/2009 | CN101484135A Pharmaceutical composition having reduced abuse potential |
| 07/15/2009 | CN101484134A Compositions of glycopyrronium salt for inhalation |
| 07/15/2009 | CN101484133A Compositions and methods for treating conditions of the nail unit |
| 07/15/2009 | CN101484132A Pleasant-tasting ranitidine formulation |
| 07/15/2009 | CN101480384A Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| 07/15/2009 | CN101480379A Wound plaster for capon |
| 07/15/2009 | CN101480378A Solid preparation of Donepezil hydrochloride and technique for preparing the same |
| 07/15/2009 | CN101480377A Method for preparing tumor enzyme-targeted nano medicine-carrying polymer microsphere |
| 07/15/2009 | CN101480376A Method of preparing particles for agglomeration |
| 07/15/2009 | CN101480375A Coenzyme Q10 intravenous transfusion and preparation method thereof |